ES2043142T3 - Procedimiento para la obtencion de (+)-1,4-dihidro-5-isopropoxi-2-metil-4-(2-trifluormetilfenil)-1,6-naftiridin-3-carboxilato de (2-(n-metil-n-fenilmetilamino)etilo) fumarato. - Google Patents

Procedimiento para la obtencion de (+)-1,4-dihidro-5-isopropoxi-2-metil-4-(2-trifluormetilfenil)-1,6-naftiridin-3-carboxilato de (2-(n-metil-n-fenilmetilamino)etilo) fumarato.

Info

Publication number
ES2043142T3
ES2043142T3 ES90103869T ES90103869T ES2043142T3 ES 2043142 T3 ES2043142 T3 ES 2043142T3 ES 90103869 T ES90103869 T ES 90103869T ES 90103869 T ES90103869 T ES 90103869T ES 2043142 T3 ES2043142 T3 ES 2043142T3
Authority
ES
Spain
Prior art keywords
methyl
dihydro
fumarate
ethyl
trifluormetilfenil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90103869T
Other languages
English (en)
Inventor
Wolfgang Dr Herrmann
Jurgen Dr Kleinschroth
Klaus Dr Steiner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Goedecke GmbH
Original Assignee
Goedecke GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Goedecke GmbH filed Critical Goedecke GmbH
Application granted granted Critical
Publication of ES2043142T3 publication Critical patent/ES2043142T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

EL INVENTO SE REFIERE A UN COMPUESTO DE FORMULA (I) Y A SUS ISOMEROS OPTICOS DE FORMULA (I'') Y (I"); TRATA DE UN PROCEDIMIENTO PARA LA PRODUCCION DEL COMPUESTO DE FORMULA (I) Y DESCRIBE SU APLICACION COMO MEDICAMENTEO PARA EL TRATAMIENTO DE LA ELEVADA PRESION SANGUINEA Y LAS ENFERMEDADES DE CORAZON Y CUERPO. SIENDO: I ESTER FUMARATO DEL ( (MAS MENOS) ) -1,4-DIHIDRO-5-ISOPROPOXI-2-METILO -4-(2-TRIFLUOROMETILOFENILO)-1,6-NAFTIRIDINA-3 ACIDO CARBONICO -2-(N-METIL-N -FENILMETIL AMINO)ETIL); II ESTER FUMARATO (+) -1,4-DIHIDRO-5-ISOPROPOXI-2METILO-4-(2-TRIFLUOROMETILOFENILO)-1,6-NAFTIRIDINA-3-ACIDO CARBONICO -2(N-METIL-N-FENILMETIL AMINO)ETIL; Y II'' EL ESTER FUMARATO (-) -1,4-DIHIDRO-5ISOPROPOXI-2-METILO-4-2-TRIFLUOROMETILOFENILO)-1,6-NAFTIRIDINA-3 ACIDO CARBONICO -(2-N-METILO-N-FENILMETIL AMINO)ETILO).
ES90103869T 1989-03-01 1990-02-28 Procedimiento para la obtencion de (+)-1,4-dihidro-5-isopropoxi-2-metil-4-(2-trifluormetilfenil)-1,6-naftiridin-3-carboxilato de (2-(n-metil-n-fenilmetilamino)etilo) fumarato. Expired - Lifetime ES2043142T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3906406A DE3906406C1 (es) 1989-03-01 1989-03-01

Publications (1)

Publication Number Publication Date
ES2043142T3 true ES2043142T3 (es) 1993-12-16

Family

ID=6375196

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90103869T Expired - Lifetime ES2043142T3 (es) 1989-03-01 1990-02-28 Procedimiento para la obtencion de (+)-1,4-dihidro-5-isopropoxi-2-metil-4-(2-trifluormetilfenil)-1,6-naftiridin-3-carboxilato de (2-(n-metil-n-fenilmetilamino)etilo) fumarato.

Country Status (8)

Country Link
US (1) US5039679A (es)
EP (1) EP0385422B1 (es)
JP (1) JPH02275880A (es)
AT (1) ATE78823T1 (es)
DE (2) DE3906406C1 (es)
DK (1) DK0385422T3 (es)
ES (1) ES2043142T3 (es)
GR (1) GR3005378T3 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9510223D0 (en) * 1995-05-20 1995-07-19 Pfizer Ltd Therapeutic agent

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5553291A (en) * 1978-10-17 1980-04-18 Nippon Kayaku Co Ltd Naphthylidine derivative and its preparation
US4304914A (en) * 1980-07-07 1981-12-08 Usv Pharmaceutical Corporation Naphthyridone derivatives
DK161312C (da) * 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
IL75987A (en) * 1984-08-25 1991-07-18 Goedecke Ag Tri-and tetrasubstituted-1,4-dihydro-1,6-naphthyridine-3-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
DE3602655A1 (de) * 1985-01-29 1987-07-30 Goedecke Ag 1,6-naphthyridin-derivate, verfahren zu deren herstellung und deren verwendung
DE3502790A1 (de) * 1985-01-29 1986-07-31 Gödecke AG, 1000 Berlin 1,6-naphthyridin-derivate, verfahren zu deren herstellung und deren verwendung
DE3431303A1 (de) * 1984-08-25 1986-02-27 Goedecke Ag 1,6-naphthyridin-derivate, verfahren zu deren herstellung und deren verwendung
US4760081A (en) * 1984-08-25 1988-07-26 Goedecke Aktiengesellschaft 1,6-naphthyridine derivatives useful for treating diseases of the blood vessels

Also Published As

Publication number Publication date
GR3005378T3 (es) 1993-05-24
US5039679A (en) 1991-08-13
DE59000219D1 (de) 1992-09-03
DE3906406C1 (es) 1990-10-25
DK0385422T3 (da) 1992-09-07
EP0385422A1 (de) 1990-09-05
EP0385422B1 (de) 1992-07-29
JPH02275880A (ja) 1990-11-09
ATE78823T1 (de) 1992-08-15

Similar Documents

Publication Publication Date Title
ATE84412T1 (de) Pharmazeutisches praeparat mit verzoegerter abgabe eines dihydropyridins und eines betaadrenorezeptor-antagonisten und herstellungsverfahren dessen.
ATA91797A (de) Eine das vwf-propeptid enthaltende pharmazeutische präparation
ES2107511T3 (es) Procedimiento para la preparacion de un concentrado de factor xi de la coagulacion sanguinea con alta actividad especifica, apropiado para su uso terapeutico.
IT9041503A0 (it) Dispositivo per la cura chirurgica dell'ametropia
ATE174798T1 (de) Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation
ES2039196T3 (es) Procedimiento para preparar 4-(1,2,5,6-tetrahidro-1-alquil-3-piridinil)-2-tiazolaminas y 4-(hexahidro-1-alquil-3-piridinil)-2-tiazolaminas.
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
ES2043142T3 (es) Procedimiento para la obtencion de (+)-1,4-dihidro-5-isopropoxi-2-metil-4-(2-trifluormetilfenil)-1,6-naftiridin-3-carboxilato de (2-(n-metil-n-fenilmetilamino)etilo) fumarato.
ES2073391T3 (es) Metodo y composiciones terapeuticas para el tratamiento de trastornos de perdidas de sangre.
NO934160D0 (no) 2-amino-1,2,3,4-tetrahydronaftalenderivater med kardiovaskul{r aktivitet, fremgangsm}te for fremstilling derav samtfarmas!ytiske preparater inneholdende slike
IT8947616A0 (it) Preparato per il trattamento e la cura delle emorroidi
BR9607996A (pt) Derivado de aminotetralina para o tratamento de doenças cardiovasculares
IT1216559B (it) Il trattamento delle malattie della procedimento per la preparazione di pelle. una composizione farmaceutica per
ITMI910658A0 (it) N-(4,5-diidrossi-e 4,5,8-triidrossi-9,10-diidro-9,10-diosso-2- antracen-il)carbonil) amminoacidi utilizzabili nella terapia delle affezioni osteoarticolari
ES2060440T3 (es) Derivados de acidos 1,4-dihidropiridin-dicarboxilicos aril-quinolil substituidos, procedimiento para su fabricacion y su uso en medicamentos.
DE3751597D1 (de) Verwendung von 15-Deoxyspergualin als Arzneimittel.
ID23176A (id) Metoda untuk mengobati gangguan pembuluh darah
AU6360486A (en) Procedure for obtaining the preparation for the treatment of the disease psoriasis; drug for the treatment of psoriasis and its application
ES2044853T3 (es) Derivados de 1,4-di-hidro-piridina, procedimiento para su fabricacion y medicamentos que contienen estos compuestos.
ES2051916T3 (es) Procedimiento para la obtencion de formiltrimetilbiciclo(2.2.2)oct-7-enos isomeros.
IT1279529B1 (it) Procedimento di preparazione ed uso degli enantiomeri (s) di derivati 1,4-diidropiridinici per il trattamento dell'insufficienza cardiaca
IT8820639A0 (it) Procedimento per la preparazione di protesi vascolari.
IT1227426B (it) Procedimento per la preparazione di 2 - (2,4 diclorofenil)metil4 - (1,1, 3,3 tetrametilbutil)fenolo (clofoctolo)
IT1230695B (it) Procedimento per la preparazione del 4-(((2-(2-tenoil)amino-3,5- dibromofenil)metil)amino)cicloesanolo
ES2085411T3 (es) Uso de heptastigmina en la terapia de ictus cerebral.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 385422

Country of ref document: ES